DE1618806C - Process for the preparation of 3,20-Dioxo-17 alpha-hydroxy-19-nor-9 beta, 10 alpha-delta to the power of 4-pregnen - Google Patents
Process for the preparation of 3,20-Dioxo-17 alpha-hydroxy-19-nor-9 beta, 10 alpha-delta to the power of 4-pregnenInfo
- Publication number
- DE1618806C DE1618806C DE1618806C DE 1618806 C DE1618806 C DE 1618806C DE 1618806 C DE1618806 C DE 1618806C
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- hydroxy
- dioxo
- pregnen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 7
- SUPOKHOQAKXOHJ-BYZMTCBYSA-N (8S,9S,10R,13R,14S,17S)-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 SUPOKHOQAKXOHJ-BYZMTCBYSA-N 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- 230000000640 hydroxylating Effects 0.000 claims description 3
- KTZGTVKCIHIUHA-UHFFFAOYSA-N ethylidenephosphane Chemical compound CC=P KTZGTVKCIHIUHA-UHFFFAOYSA-N 0.000 claims description 2
- 238000005805 hydroxylation reaction Methods 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- VUVGYHUDAICLFK-UHFFFAOYSA-N Perosmic oxide Chemical compound O=[Os](=O)(=O)=O VUVGYHUDAICLFK-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- -1 keto steroids Chemical class 0.000 description 3
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Chemical compound [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- FBMXBXAYQCWEOC-PNKHAZJDSA-N (8R,9S,10R,13S,14S)-13-methyl-1,2,3,6,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 FBMXBXAYQCWEOC-PNKHAZJDSA-N 0.000 description 2
- JMSRBKPMLUGHCR-UHFFFAOYSA-N Bromohydrin Chemical compound BrC[C]1CO1 JMSRBKPMLUGHCR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L Sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N Tert-Amyl alcohol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atoms Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- SBNLPRGISFUZQE-VMXHOPILSA-N (8S,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene Chemical compound C1C=C2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 SBNLPRGISFUZQE-VMXHOPILSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-Methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N 2-Pyrrolidone Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- YROIHKKJDMNYRB-UHFFFAOYSA-N 2-acetyloxyethylphosphonic acid Chemical compound CC(=O)OCCP(O)(O)=O YROIHKKJDMNYRB-UHFFFAOYSA-N 0.000 description 1
- LTYRAPJYLUPLCI-UHFFFAOYSA-N 2-hydroxyacetonitrile Chemical class OCC#N LTYRAPJYLUPLCI-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 210000002356 Skeleton Anatomy 0.000 description 1
- 206010065954 Stubbornness Diseases 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N Talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N Trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 238000006137 acetoxylation reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- JHYNXXDQQHTCHJ-UHFFFAOYSA-M ethyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC)C1=CC=CC=C1 JHYNXXDQQHTCHJ-UHFFFAOYSA-M 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Description
FUr die Teilsynthese von Cortisonhormonen war der Abbau einer lateralen Kette oinos Steroids mit 24 oder 27 Kohlenstoffatom?!! seinerzeit eine schwierige Aufgabe.For the partial synthesis of cortisone hormones, the breakdown of a lateral chain of oinos steroid was necessary 24 or 27 carbon atom? !! a difficult task at the time.
Bei der Totalsynthese von Steroiden liegt zur Zeil das umgekehrte Problem vor. Bei diesen üerstcllungsverfahren baut man zuerst das tetracyclischo Skelett auf, geht im allgemeinen bis zu einem Cyclopentanopolyhydrophenanthren mit einer Hydroxyl- oder Ketonfunklion in 17-Stellung (vergleiche z.B. LVcIIu ζ und Mitarbeiter, C. R. Acad, des Sciences, Bd. 250, S. 1084, 1293 und 1510 [I960]), und es ergibt sich dann das Problem des Aufbau» einer lateralen Kette mit 2 Kohlenstoffatomen am Ring D in 17-Stellung und der Einführung einer Hydroxylgruppe in der gleichen Stellung,In the case of the total synthesis of steroids, the opposite problem is present for the Zeil. With these transfer procedures If you first build up the tetracyclic skeleton, you generally go as far as a cyclopentanopolyhydrophenanthrene with a hydroxyl or ketone function in the 17-position (compare e.g. LVcIIu ζ and coworkers, C. R. Acad, des Sciences, Vol. 250, pp. 1084, 1293 and 1510 [1960]), and es The problem then arises of the structure of »a lateral chain with 2 carbon atoms on ring D. in the 17-position and the introduction of a hydroxyl group in the same position,
CN CNCN CN
OH —OH -
Die bis jetzt benutzten Wege zur Lösung dieses Problems gehen entweder über ein Cyanhydrin in 17-Stellung oder über ein 17-Älhinylderivat.The methods used up to now to solve this problem are either via a cyanohydrin in 17-position or via a 17-Älhinylderivat.
Die erstgenannte Arbeitsweise ist umständlich und langwierig, da sie nach der Bildung des Cyanhydrine eine Wasserabspaltung aus demselben zum 17-Cyano-16,17-dehydroderivat, eine Grignard-Reaktion mit dem Nitril, um das entsprechende Methylketon zu erhalten, und dann die Einführung der Hydroxylgruppe in 17-Stellung erfordert, die noch drei weitere Sturen mit sich bringt: die Bildung des 16,17-Epoxyds, die Umwandlung desselben ins Bromhydrin und die Reduktion von Brom. Insgesamt sind dies sechs Stufen, die wie folgt schematisch wiedergegeben werden können:The first-mentioned working method is cumbersome and tedious, as it is after the formation of the cyanohydrins an elimination of water from the same to form 17-cyano-16,17-dehydroderivat, a Grignard reaction with the nitrile to give the corresponding methyl ketone, and then the introduction of the hydroxyl group in the 17-position, which brings with it three more stubbornness: the formation of the 16,17-epoxy, the conversion of this into bromohydrin and the reduction of bromine. There are six in total Levels, which can be shown schematically as follows:
CH1 CH 1
CO
OHCO
OH
CH3
COCH 3
CO
OHOH
Die Arbeitsweise, welche auf die Äthinylierung ergeben, wodurch das Brom in 21-Stellung erscheintThe procedure which resulted in the ethynylation, whereby the bromine appears in the 21-position
zurückgreift, ist nicht viel schneller. Das 17/f-Hydroxy- unter gleichzeitiger Verlagerung der Doppelbindungfalling back isn't much faster. The 17 / f-hydroxy- with simultaneous displacement of the double bond
17a-äthinylsteroid wird zuerst zum entsprechenden 20-21 in 17,20-Stellung. Durch Acetoxylierung und17a-ethinyl steroid first becomes the corresponding 20-21 in the 17,20 position. By acetoxylation and
Vinylderivat reduziert, dann wird das Hydroxyl 30 hydroxylierende Oxydation erhält man dann einVinyl derivative reduced, then the hydroxyl 30 hydroxylating oxidation is then obtained
in den Bromhydrinäther unter den Bedingungen 17a-hydroxy-20-oxo-21-acetoxyliertes Derivat,
übergeführt, welche gleichzeitig eine Allylumlagerungin the bromohydrin ether under the conditions 17a-hydroxy-20-oxo-21-acetoxylated derivative,
transferred, which at the same time an allyl rearrangement
Diese Arbeitsweise, welche demnach gemäß dem folgenden Schema fünf Stufen umfaßtThis procedure, which accordingly comprises five stages according to the following scheme
OHOH
OHOH
- C == CH -- C == CH -
- CH = CH, OAc CH2 — OAc- CH = CH, OAc CH 2 - OAc
hat einen schwerwiegenden Nachteil, nämlich die Schwierigkeiten der Bromierungsstufe. Diese Reaktion ist mit guten Ausbeuten mitunter schwer durchführbar und kann bei gewissen Steroiden völlig versagen.has a serious disadvantage, namely the difficulty of the bromination step. This reaction is sometimes difficult to carry out with good yields and can be completely with certain steroids fail.
Man weiß andererseits, daß (vgl. insbesondere F. Sondheimer und R. Mechoulam, JA.C.S., 79, S. 5029 [1957]) verschiedene Ylide des Phosphors mit Ketosteroiden kondensiert werden können, jedoch haben die erhaltenen Produkte, wie beispielsweise im Falle von 3/J-Hydroxy-17-methylen-/I5-androsten, keinen praktischen Wert für die Lösung des frag-, liehen Problems.On the other hand, it is known that (cf. in particular F. Sondheimer and R. Mechoulam, JA.CS, 79, p. 5029 [1957]) various ylides of phosphorus can be condensed with keto steroids, but the products obtained have, for example, in the case of 3 / I-hydroxy-17-methylene / I 5 -androsten, no practical value for the solution of the questionable, borrowed problem.
Andere Autoren sind bei ihren Versuchen, Phosphonoäthylacetat mit der 17-ständigen Ketogruppe von Steroiden reagieren zu lassen, völlig gescheitert (s. insbesondere A. K. B ο s e und Mitarbeiter (Tetrahedron Letters Nr. 15, S. 959 bis 963 [1963]).Other authors are in their attempts to use phosphonoethyl acetate with the 17-position keto group reacting with steroids completely failed (see in particular A. K. B o s e and coworkers (Tetrahedron Letters No. 15, pp. 959 to 963 [1963]).
Gegenstand der Erfindung ist ein Verfahren zur Herstellung von S^O-Dioxo-na-hydroxy-^-nor-9/J,10a-zl4-pregnen, das dadurch gekennzeichnet ist, daß man 3-Pyrrolidyl-17-oxo-9/S,10a-/J3i5-östradien mit einem Carbanion eines Äthylidenphosphorans kondensiert, das erhaltene Produkt hydrolysiert und in an sich bekannter Weise hydroxylierend oxydiert.The invention relates to a process for the preparation of S ^ O-dioxo-na-hydroxy - ^ - nor-9 / J, 10a-zl 4 -pregnen, which is characterized in that 3-pyrrolidyl-17-oxo-9 / S, 10a- / J 3i5 -estradiene is condensed with a carbanion of an ethylidene phosphorane, the product obtained is hydrolyzed and oxidized by hydroxylation in a manner known per se.
Die Kondensation der Äthylidenphosphorane mitThe condensation of Äthylidenphosphorane with
17-Ketosteroiden führt zu 17-ÄthyIidenderivaten, die nach dem folgenden Schema leicht in 17a-Hydroxy-20-oxosteroide überführbar sind:17-ketosteroids leads to 17-ethylidene derivatives, the can easily be converted into 17a-hydroxy-20-oxosteroids according to the following scheme:
CH,CH,
CHCH
CH3 CH 3
-/- OH - / - OH
Die hydroxylierende Oxydation des 17-Äthylidensteroids ist in an sich bekannter Weise durch Einwirkung von Osmiumtetroxyd in einem tertiären Alkohol, wie beispielsweise tert.-Butylalkohol oder tert.-Amylalkohol, in Gegenwart eines Peroxyds des Oxyds eines tertiären Amins, wie beispielsweise demjenigen von Trimethylamin, Triäthylamin, Picolin u. dgl., leicht durchführbar.The hydroxylative oxidation of the 17-ethylidene steroid is in a known manner by the action of osmium tetroxide in a tertiary Alcohol, such as tert-butyl alcohol or tert-amyl alcohol, in the presence of a peroxide des Oxide of a tertiary amine, such as that of trimethylamine, triethylamine, picoline and the like, easy to carry out.
1010
Herstellung von ^Dioxonahydroxy^noProduction of ^ Dioxonahydroxy ^ no
9/i,10a-/l4-prcgnen, ausgehend von 3-Pyrrolidyl9 / i, 10a / l 4 -prcgnen, starting from 3-pyrrolidyl
17-oxo-9//,10«"/Ja'5-östradien.17-oxo-9 //, 10 "" / J a ' 5 -estradien.
Stufe ALevel a
3-Oxo-19-nor-9/i, 10«-/|4-l7(20)-pregnadien
Herstellung des Ausgangsmaterials und des Reagens3-Oxo-19-nor-9 / i, 10 "- / | 4 - l7 (20) -pregnadien
Preparation of the starting material and the reagent
a) Man gibt 4,8 g einer 55%igen Suspension von Natriumhydrid in Mineralöl zu 40 ecm wasserfreiem Dimethylsulfoxyd und rührt 45 Minuten unter Stickstoffatm osphilre bei einer Temperatur von 8O'bis 85° C.a) 4.8 g of a 55% suspension of sodium hydride in mineral oil are added to 40 ecm anhydrous Dimethyl sulfoxide and stirred for 45 minutes under nitrogen atmosphere at a temperature of 80 ° to 85 ° C.
Man kühlt dann auf Zimmertemperatur ab, versetzt mit 39 g Triphenyläthylphosphoniumbromid in Suspension in 80 ecm wasserfreiem Dimethylsulfoxyd und rührt während einer Viertelstunde.It is then cooled to room temperature, 39 g of triphenylethylphosphonium bromide are added in suspension in 80 ecm of anhydrous dimethyl sulfoxide and stirred for a quarter of an hour.
b) Zur Erläuterung wird die Herstellung von 3-Pyrrolidyl -17 - oxo - 9 β, 1 Ou - Δ3 ·5 - östradien beschrieben: Zu einer Lösung von 0,6 g 3-Oxo-9|3,10a-17/<-hydroxy-/l4-östren in 120 ecm Aceton gibt man die Lösung von 218 mg Chromsäureanhydrid in 0,2 ecm Schwefelsäure und 12 ecm Wasser zu.b) The preparation of 3-pyrrolidyl -17-oxo-9 β, 1 Ou- Δ 3 · 5 -estradiene is described for explanation: To a solution of 0.6 g 3-oxo-9 | 3,10a-17 / <-hydroxy- / l 4 -estrene in 120 ecm acetone, the solution of 218 mg chromic anhydride in 0.2 ecm sulfuric acid and 12 ecm water is added.
Das Gemisch wird 4 Stunden bei Zimmertemperatur gerührt und dann mit Wasser gefällt und mit Methylenchlorid extrahiert. Die organischen Extrakte werden nach Waschen mit einer wäßrigen Natriumbicarbonatlösung über Natriumsulfat getrocknet und dann destilliert. Man isoliert das rohe Diketon in praktisch quantitativer Ausbeute.The mixture is stirred for 4 hours at room temperature and then precipitated with water and with Extracted methylene chloride. The organic extracts are washed with an aqueous sodium bicarbonate solution dried over sodium sulfate and then distilled. The crude diketone is isolated in practically quantitative yield.
Durch Anteigen in 1,8 ecm Isopropyläther erhält man 540 mg 3,17-Dioxo-9/!),10a-/l4-östren vom F. = 135°C.'Pasting in 1.8 ecm of isopropyl ether gives 540 mg of 3,17-dioxo-9 /!), 10a / l 4 -estrene with a temperature of 135 ° C. '
Man gibt 2 ecm Pyrrolidon zu 1,005 g 3,17-Dioxo-9ß,10a-/l4-östren und erhitzt 10 Minuten auf 85 bis 900C. Zu der heißen Lösung gibt man 30 ecm Me-, thanol. Das 3-Pyrrolidyl-17-oxo-9//,10a-/l3·5-östradien kristallisiert im Milieu aus. Man trennt durch einfaches Absaugen und erhält 1,07 g des Produktes vom F. = 1600C.Priority 2 ecm pyrrolidone to 1.005 g 3,17-dioxo-9SS, 10a-/ l -estrene 4 and heated for 10 minutes 85 to 90 0 C. To the hot solution is 30 to ECM Me, THANOL. The 3-pyrrolidyl-17-oxo-9 //, 10a- / l 3 · 5 -estradiene crystallizes out in the medium. It is separated by simple suction and 1.07 g of the product with a F. = 160 ° C.
Kondensationcondensation
Man gibt 3,1 g 3 - Pyrrolidyl -17 - oxo - 9/ί,10<ί-.I3i5-östradien in die nach der obigen Vorschrift hergestellte Suspension und rührt während 23 Stunden unter Stickstoffatmosphäre bei einer Temperatur von 50 bis 55°C.3.1 g of 3-pyrrolidyl-17-oxo-9 / ί, 10 <ί-.I 3i5 -estradiene are added to the suspension prepared according to the above procedure and the mixture is stirred for 23 hours under a nitrogen atmosphere at a temperature of 50 to 55 ° C.
3535
40 Man kllhlt a.b. nimmt in Wasser und Benzol auf, wuscht die Benzolphase mil Wasser und extrahiert dann mit 1 n-Salzsäure, 40 It is cooled, taken up in water and benzene, the benzene phase is washed with water and then extracted with 1N hydrochloric acid,
Man läßt die saure Lösung während einer Stunde stehen und macht sie dann mit 1 n-NaOH alkalisch. Man extrahiert den erhaltenen Niederschlag mit Methylenchlorid, wäscht, trocknet und verdampft die organische Phase.The acidic solution is left to stand for one hour and then made alkaline with 1N NaOH. The precipitate obtained is extracted with methylene chloride, washed, dried and evaporated the organic phase.
Man Chromatographien das erhaltene Produkt an Magnesiumsilikat und eluiert mit Methylenchlorid, das 0,5% Aceton enthält. Man kristallisiert aus Isopropylälher um und gewinnt 1,344 g 3-Oxo-19-nor-9p,10a-/'l4'17(Z0)-pregnadienThe product obtained is chromatographed on magnesium silicate and eluted with methylene chloride containing 0.5% acetone. It is recrystallized from isopropyl ether and 1.344 g of 3-oxo-19-nor-9p, 10a - / 'l 4 ' 17 (Z0) -pregnadiene are obtained
vom F. - 9O0C.from F. - 9O 0 C.
Das Produkt wurde in der Literatur noch nicht beschrieben.The product has not yet been described in the literature.
Stufe BLevel B.
3,20-Dioxo-17 «-hydroxy-19-nor-9/J, 10u-/J4-pregnen3,20-Dioxo-17 "-hydroxy-19-nor-9 / J, 10u / J 4 -pregnen
Man gibt 1,344 g 3-Oxo-19-nor-9/J,10a-.l4·17'201-pregnadien in 80 ecm tert.-Butanol, versetzt mit 2 ecm einer Lösung von 0,17 g Osmiumtetroxyd in 6 ecm Pyridin und rührt während 40 Minuten bei Zimmertemperatur.One gives 1.344 g of 3-oxo-19-nor-9 / J, 10a-.l 4 x 17 '201 -Pregnadien in 80 cc of tert-butanol, treated with 2 cc of a solution of 0.17 g of osmium tetroxide in 6 cc Pyridine and stir for 40 minutes at room temperature.
Zu dem Reaktionsgemisch gibt man dann anteilweise innerhalb 40 Minuten 1,44 g Triäthylaminooxydperoxyd, rührt eine Viertelstunde, gießt in Wasser, das mit Natriumsulfit versetzt ist, extrahiert mit Methylenchlorid, wäscht mit Wasser, trocknet und verdampft zur Trockne.1.44 g of triethylamino oxide peroxide are then added to the reaction mixture in part over the course of 40 minutes. stir for a quarter of an hour, pour into water to which sodium sulfite has been added, extracted with Methylene chloride, washed with water, dried and evaporated to dryness.
Man reinigt das Produkt durch Umkristallisieren aus Aceton und dann aus Äthanol und erhält 0,660 g 3,20-Dioxo- 17a-hydroxy-19-nor-9j3,10a-/l4-pregnen vom F. ^ 255° C.The product is purified by recrystallization from acetone and then from ethanol and 0.660 g of 3,20-dioxo-17a-hydroxy-19-nor-9j3,10a- / l 4 -pregnen with a temperature of ^ 255 ° C. is obtained.
Das Produkt wurde in der Literatur noch nicht beschrieben.The product has not yet been described in the literature.
Claims (1)
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1468035A1 (en) | Process for the preparation of 19-alkyl steroids | |
DE1618806C (en) | Process for the preparation of 3,20-Dioxo-17 alpha-hydroxy-19-nor-9 beta, 10 alpha-delta to the power of 4-pregnen | |
DE1618806B1 (en) | Process for the production of 3,20-Dioxo-17Alfa-hydroxy-19-nor-9Beta, 10Alfa-Delta4-pregnen | |
DE1222920B (en) | Process for the preparation of 19-methylene derivatives of the androstane series which are substituted in the 3-position by an oxygen-containing substituent | |
DE1618808C (en) | Process for the production of the 10, 11 lactone deep 5 of the 3 ethylenedioxy 11 beta, 17 alpha dihydroxy 20 oxo-19 nor Delta high 5 pregnen 10 beta carboxylic acid | |
CH494213A (en) | Gona-4 9-dien-3-ones | |
US3096350A (en) | 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof | |
DE1618875C3 (en) | Process for the preparation of Salpha-halogen-öbeta-acyl-oxysteroids | |
DE2248834A1 (en) | METHOD FOR MANUFACTURING BETA (3-KETO-7 ALPHA-ACETYLTHIO-17BETA-HYDROXY4-ANDROSTEN-17 ALPHA-YL) -PROPIONIC ACID GAMMA -LACTONE | |
DE960200C (en) | Process for the preparation of 4-pregnen-16 ª ‡ -ol-3, 20-diones | |
DE909935C (en) | Process for the preparation of í¸-3-oxysteroids or their derivatives | |
DE1643028C3 (en) | New 1,2 alpha -methylene steroids, processes for their production and agents containing them | |
DE1939507C3 (en) | Process for the preparation of 17 a-acyloxy-20- | |
DE1468227C (en) | Process for the production of delta to the power of 4 or delta to the power of 5 unsaturated steroids of the androstane, pregnane and sapogenin series with a free or esterified hydroxyl group in the 19 position | |
DE843411C (en) | Process for the production of pregnane derivatives substituted in the 21-position | |
DE2110140B2 (en) | ||
DE1643008C3 (en) | Process for making 17 ethynyl delta to the power of 16 steroids | |
DE932795C (en) | Process for the preparation of A8 (9) -7, 11-dioxy compounds of the cyclopentanopolyhydrophenanthrene series | |
DE1264441B (en) | Process for the production of 17alpha-AEthynyl-delta 5 (10-19-nor-androsten-17beta-ol-3-one and 17alpha-AEthynil-19-nor-testosterone and its esters | |
DE1468880C (en) | Process for the preparation of 17,20-dehydro-steroids | |
CH361802A (en) | Method of making steroids | |
DE1643008A1 (en) | 17-AEthinyl-1? -Steroids and process for their preparation | |
DE1092013B (en) | Process for the production of methyl steroids | |
DE1593505B2 (en) | ||
DE1241825B (en) | Process for the production of 6 chlorine 4 6diLirverbindungen of the pregnan, androstan or cholestan series |